Versatile

Educational and Networking Events for the Life Sciences Industry

Information

Join Our Mailing List

Please enter your contact details below in order to receive regular updates and discount offers for this conference.

First Name           
Last Name           
Job Title                
Company             
Email Address    

Join our Pain Drug Development Group

linkedin.1.u

Gold Sponsor

 

Lifetree Clinical Research® is in the forefront of experimental pain models (UVB, Capsaicin, Micro-Incision and Cold Pressor) in healthy volunteers to demonstrate efficacy early in drug development. CNS, Analgesia, Human Abuse Liability, and CSF are Lifetree’s sought after niche services. Clients look to Lifetree for quality Site and CTM Services.

Silver Sponsor

algos_logo

Algos is a premier contract research organization specializing in preclinical pain in rodent models. They perform Proof-of concept, Screening and Efficacy studies in a wide range of in vivo models including neuropathic, post-surgical, visceral and inflammatory pain. Their expertise, quality and customer service enable clients to augment their drug discovery efforts.

Last Year's Conference

Please CLICK HERE to view last year's conference agenda

lastyearsconference

Networking Opportunities

Attendees will have the opportunity to network before during and after the event through the following services:

  • ONLINE NETWORKING software available prior to and after the event
  • ONE-to-ONE meeting space
  • NETWORKING breaks
  • End of day RECEPTION
 

 

Friday, 26 February 2010 17:32

The full list of speakers for this conference is not yet available. Please check back in the coming weeks for more information.

Frank Porreca, Ph.D., Professor of Pharmacology and Anesthesiology, University of Arizona

Michael Grey, Venture Partner, Pappas Ventures

Deborah Leiderman, MD, Principal, CNS Drug Consulting LLC (Former: Director, Controlled Substances, FDA Center for Drug Evaluation & Research)

Bradley Galer, MD, President, Pain Group, Nuvo Research Inc.

Philip R. Kym, Ph.D., Associate Director II, Pain Discovery Research, Abbott Laboratories

William K. Schmidt, Ph.D., Vice President, CrystalGenomics & CG Pharmaceuticals

John J. Coleman, Ph.D., President, Prescription Drug Research Center

Christopher deCharms, Ph.D., CEO, Omneuron, Inc.

Christine Rauschkolb, MD, Ph.D., VP Pain Development, Johnson & Johnson

Arnold Gammaitoni, Pharm.D., VP, Scientific Affairs, Nuvo Research, Inc.

Dr. Joseph Stauffer, Chief Medical Officer & VP, Corporate Strategy, PharmacoFore, Inc.

Nancy Lane, MD, Endowed Professor of Medicine, University of California, Davis

Pamela Palmer, MD, Chief Medical Officer, AcelRx Pharmaceuticals

Anthony P. Ford, Ph.D., Chief Scientific Officer, Afferent Pharmaceuticals

Gary Patou, MD, Interim Chief Medical Officer, Pacira Pharmaceuticals

Greg Stewart, Ph.D., Director, CNS Drug Therapy R&D, Medtronic

Laura Bohn, Ph.D., Associate Professor, Scripps Research Institute

James Vornov, MD, Ph.D., CNS Therapeutic Area Leader, PAREXEL International

Rajesh Khanna, Ph.D., Assistant Professor, Department of Pharmacology and Toxicology, Stark Neurosciences Research Institute, Indiana University School of Medicine